Journals / International Journal of Chemistry and Technology / 2026 / Volume: 9 Issue: 1

Biological Activities of Leucoagaricus leucothites Mushroom: Evaluation of Antioxidant, Anticholinesterase and Antiproliferative Effects

Celal Bal(Univercity of Gaziantep)0000-0001-6856-3254
Pages
—
Publication Date
2025-06-24
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings show that L. leucothites can be used in health supportive treatment approaches and can be a valuable source in pharmaceutical applications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mushrooms have constituted a wide research area as natural resources exhibiting medically important biological activities.
📊
Key Findings & Data:A549 lung cancer cell line was used to determine the antiproliferative effect.
💡
Conclusion & Impact:These findings show that L. leucothites can be used in health supportive treatment approaches and can be a valuable source in pharmaceutical applications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Leucoagaricus · antioxidant activity · anticholinesterase activity

Abstract

Mushrooms have constituted a wide research area as natural resources exhibiting medically important biological activities. This study aimed to investigate the biological activities of Leucoagaricus leucothites (Vittad.) Wasser mushroom comprehensively. Ethanol extract of the mushroom was obtained by Soxhlet extraction method. To determine the biological potential of the extract, total antioxidant status (TAS) and total oxidant status (TOS) analyses were performed by Rel Assay kits. In addition, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme activities were measured to evaluate the anticholinesterase activity of the mushroom. A549 lung cancer cell line was used to determine the antiproliferative effect. The obtained data showed that the TAS value of L. leucothites was 6.109±0.078 mmol/L and the TOS value was 15.364±0.149 µmol/L. Oxidative stress index (OSI) was calculated as 0.251±0.003. In terms of anticholinesterase activity, AChE inhibition value was found as 106.08±1.76 µg/mL, BChE inhibition value was found as 129.88±1.62 µg/mL. Antiproliferative effect increased in parallel with the increase in concentration, and this situation revealed that L. leucothites has a strong potential in terms of biological activities. These findings show that L. leucothites can be used in health supportive treatment approaches and can be a valuable source in pharmaceutical applications.

🔖

Cite This Article

Bal, C. (2025). Biological Activities of Leucoagaricus leucothites Mushroom: Evaluation of Antioxidant, Anticholinesterase and Antiproliferative Effects. International Journal of Chemistry and Technology, Volume: 9 Issue: 1. https://doi.org/10.32571/ijct.1668272

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (40)

  1. Sevindik, M.; Akgul, H.; Selamoglu, Z.; & Braidy, N. Oxid Med Cell Longev. 2020, (1), 5620484.
  2. Eraslan, E. C.; Altuntas, D.; Baba, H.; Bal, C.; Akgül, H.; Akata, I.; & Sevindik, M. Sigma J Eng Nat Sci. 2021, 39(1), 24-28.
  3. Chugh, R.M.; Mittal, P.; Mp, N.; Arora, T.; Bhattacharya, T.; Chopra, H.;. & Gautam, R. K. Front. pharmacol. 2022, 13, 925387.
  4. Venturella, G.; Ferraro, V.; Cirlincione, F.; & Gargano, M.L. Int. J. Mol. Sci. 2021, 22(2), 634.
  5. Bal, C.; Eraslan, E.C.; & Sevindik, M. Prospect. Pharm. Sci. 2023, 21(2), 37-41.
  6. Sevindik, M.; Bal, C.; Eraslan, E. C.; Uysal, I.; & Mohammed, F.S. Prospect. Pharm. Sci. 2023, 21(2), 42-56.
  7. Mushtaq, W.; Baba, H.; Akata, I.; & Sevindik, M. KSÜ Tar Doga Derg. 2020, 23(3), 592-595.
  8. Bhambri, A.; Srivastava, M.; Mahale, V.G.; Mahale, S.; & Karn, S.K. Front Microbiol. 2022, 13, 837266.
  9. Emsen, B.; & Guven, B. Plant Biosyst. 2020, 154(3), 361-368.
  10. Aslim, B.; & Ozturk, S. J Med Food. 2011, 14(11), 1419-1424.
  11. Sevindik, M.; Rasul, A.; Hussain, G.; Anwar, H.; Zahoor, M.K.; Sarfraz, I.;. & Selamoglu, Z. Pak. J. Pharm. Sci. 2018, 31(5 (Supplementary)), 2163-2168.
  12. Vellinga, E.C.; Kok, R.P.; & Bruns, T.D. Mycologia. 2003, 95(3), 442-456.
  13. Erel O. Clin. Biochem. 2004, 37(4): 277-285.
  14. Erel O. Clin. Biochem. 2005, 38(12): 1103-1111.
  15. Sevindik, M. Fresenius Environ. Bull. 2019, 28(5), 3713-3717.
  16. Ellman, G. L.; Courtney, K.D.; Andres Jr, V.; & Featherstone, R.M. Biochem. Pharmacol. 1961, 7(2), 88-95.
  17. Bal, C.; Akgul, H.; Sevindik, M.; Akata, I.; & Yumrutas, O. Fresenius Environ. Bull. 2017, 26(10), 6246-6252.
  18. Islek, C.; Saridogan, B. G. O.; Sevindik, M.; & Akata, I. Fresenius Environ. Bull. 2021, 30(6), 6109-6114.
  19. Saridogan, B. G. O.; Islek, C.; Baba, H.; Akata, I.; & Sevindik, M. Fresenius Environ. Bull. 2021, 30(5), 5400-5404.
  20. Baba, H.; Sevindik, M.; Dogan, M.; Akgül, H. Fresenius Environ. Bull. 2020, 29(9). 7840-7846.
  21. Krupodorova, T.; Sevindik, M. Agrolife Sci J. 2020, 9(1), 186-191.
  22. Gürgen, A.; Sevindik, M. J Food Process Pres. 2022, 46(11), e16949.
  23. Gürgen, A.; Unal, O.; & Sevindik, M. Int. J. Med. Mushrooms. 2024, 26(12), 63-74.
  24. Sevindik, M.; Gürgen, A.; Khassanov, V.T.; & Bal, C. Foods. 2024, 13(10), 1560.
  25. Gürgen, A.; & Sevindik, M. Int. J. Med. Mushrooms. 2025, 27(2), 59-73.
  26. Ünal, O.; Gürgen, A.; Krupodorova, T.; Sevindik, M.; Kabaktepe, Ş.; & Akata, I. BMC complement. med. ther. 2025, 25, 113.
  27. Sevindik, M.; Bal, C.; Krupodorova, T.; Gürgen, A.; Eraslan, E.C. BMC Biotechnol. 2025, 25, 25 (2025).
  28. Chen, X.J.; Deng, Z.; Zhang, L.L.; Pan, Y.; Fu, J.; Zou, L.;. & Sheng, F. Biomed Pharmacother. 2024, 172, 116222.
  29. Akata, I.; Zengin, G.; Picot, C.M.N.; Mahomoodally, M.F.S. Afr. J. Bot. 2019, 120, 95-99.
  30. Hyder, M.S.; Dutta, S.D. Biocatal. Agric. Biotechnol. 2021, 35, 102085.
  31. Pandya, U.; Dhuldhaj, U.; & Sahay, N.S. Nat Prod Res. 2019, 33(18), 2668-2680.
  32. Zhao, Y.; Zheng, W. J. Ethnopharmacol. 2021, 265, 113321.
  33. Lian, W.; Yang, X.; Duan, Q.; Li, J.; Zhao, Y.; Yu, C.;. & Wang, W. Molecules. 2024, 29(11), 2516.
  34. Kim, S. H.; Jakhar, R.; & Kang, S. C. Saudi J. Biol. Sci. 2015, 22(4), 484-490.
  35. Sevindik, M. Indian J. Tradit. Knowl. 2020, 19(2), 423-427.
  36. Sevindik, M.; Bal, C. Int. J. Med. Mushrooms. 2021, 23(11).
  37. Chugh, R.M.; Mittal, P.; Mp, N.; Arora, T.; Bhattacharya, T.; Chopra, H.;. & Gautam, R. K. Front. pharmacol. 2022, 13, 925387.
  38. Sevindik, M.; Rasul, A.; Hussain, G.; Anwar, H.; Zahoor, M.K.; Sarfraz, I.;. & Selamoglu, Z. Pak. J. Pharm. Sci. 2018, 31(5 (Supplementary)), 2163-2168.
  39. Chen, X.J.; Deng, Z.; Zhang, L.L.; Pan, Y.; Fu, J.; Zou, L.;. & Sheng, F. Biomed Pharmacother. 2024, 172, 116222.
  40. Lian, W.; Yang, X.; Duan, Q.; Li, J.; Zhao, Y.; Yu, C.;. & Wang, W. Molecules. 2024, 29(11), 2516.